Loading clinical trials...
Loading clinical trials...
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Conditions
Interventions
Placebo
ATX-101 (1 mg/cm^2)
+2 more
Locations
20
United States
Total Skin & Beauty Dermatology Center
Birmingham, Alabama, United States
Clinical Testing Center Beverly Hills
Beverly Hills, California, United States
Mokusiga, Inc
Beverly Hills, California, United States
Plastic & Reconstructive Surgery
San Francisco, California, United States
Dermatology Institute of DuPage Medical Group in Naperville
Naperville, Illinois, United States
Skin Care Physicians
Chestnut Hill, Massachusetts, United States
Start Date
February 1, 2009
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
February 17, 2020
NCT07310264
NCT06290258
NCT06716502
NCT00090662
NCT07483606
NCT07310901
Lead Sponsor
Kythera Biopharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions